| Dr Rashno Davoodi, MD | |
|
18100 Ne Union Hill Rd, Ste 200, Redmond, WA 98052-3330 | |
| (206) 320-5190 | |
| (206) 320-5191 |
| Full Name | Dr Rashno Davoodi |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 18 Years |
| Location | 18100 Ne Union Hill Rd, Redmond, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225289192 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD60107153 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Swedish Issaquah | Issaquah, WA | Hospital |
| Evergreenhealth Medical Center | Kirkland, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Swedish Health Services | 9537072814 | 323 |
News Archive
Standing before a roomful of economists, policy makers and health care experts earlier this month, Amitabh Chandra, director of Health Policy Research at Harvard's Kennedy School of Government, closed a presentation about the slowdown in health care spending over the last decade by citing an article in The New York Times.
A new research discovery published in the April 2014 issue of the Journal of Leukocyte Biology may open the door to new therapies that help treat immune disorders or curb runaway inflammation. Specifically, scientists have discovered a molecule that can induce cell death (apoptosis) in a key type of immune cell (dendritic cells).
The Scleroderma Research Foundation today reported that researchers at The Johns Hopkins University have discovered that some cases of scleroderma are likely to have been initiated by cancer.
Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for ACTEMRA® (tocilizumab) for the prevention of structural joint damage (as assessed by radiograph) and improvement in physical function in adults with moderately to severely active rheumatoid arthritis (RA).
R-Japan Co.,Ltd. obtained the license of cell processing facility under the Act on the Safety of Regenerative Medicine from the Ministry of Health, Labour and Welfare Kinki Bureau of Health and Welfare on June 29, 2015.
› Verified 3 days ago
| Entity Name | Swedish Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831139724 PECOS PAC ID: 9537072814 Enrollment ID: O20031112000189 |
News Archive
Standing before a roomful of economists, policy makers and health care experts earlier this month, Amitabh Chandra, director of Health Policy Research at Harvard's Kennedy School of Government, closed a presentation about the slowdown in health care spending over the last decade by citing an article in The New York Times.
A new research discovery published in the April 2014 issue of the Journal of Leukocyte Biology may open the door to new therapies that help treat immune disorders or curb runaway inflammation. Specifically, scientists have discovered a molecule that can induce cell death (apoptosis) in a key type of immune cell (dendritic cells).
The Scleroderma Research Foundation today reported that researchers at The Johns Hopkins University have discovered that some cases of scleroderma are likely to have been initiated by cancer.
Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for ACTEMRA® (tocilizumab) for the prevention of structural joint damage (as assessed by radiograph) and improvement in physical function in adults with moderately to severely active rheumatoid arthritis (RA).
R-Japan Co.,Ltd. obtained the license of cell processing facility under the Act on the Safety of Regenerative Medicine from the Ministry of Health, Labour and Welfare Kinki Bureau of Health and Welfare on June 29, 2015.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rashno Davoodi, MD Po Box 25608, Salt Lake City, UT 84125-0608 Ph: (206) 320-4476 | Dr Rashno Davoodi, MD 18100 Ne Union Hill Rd, Ste 200, Redmond, WA 98052-3330 Ph: (206) 320-5190 |
News Archive
Standing before a roomful of economists, policy makers and health care experts earlier this month, Amitabh Chandra, director of Health Policy Research at Harvard's Kennedy School of Government, closed a presentation about the slowdown in health care spending over the last decade by citing an article in The New York Times.
A new research discovery published in the April 2014 issue of the Journal of Leukocyte Biology may open the door to new therapies that help treat immune disorders or curb runaway inflammation. Specifically, scientists have discovered a molecule that can induce cell death (apoptosis) in a key type of immune cell (dendritic cells).
The Scleroderma Research Foundation today reported that researchers at The Johns Hopkins University have discovered that some cases of scleroderma are likely to have been initiated by cancer.
Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for ACTEMRA® (tocilizumab) for the prevention of structural joint damage (as assessed by radiograph) and improvement in physical function in adults with moderately to severely active rheumatoid arthritis (RA).
R-Japan Co.,Ltd. obtained the license of cell processing facility under the Act on the Safety of Regenerative Medicine from the Ministry of Health, Labour and Welfare Kinki Bureau of Health and Welfare on June 29, 2015.
› Verified 3 days ago
Sonia Edith Zwilling, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8980 161st Ave Ne, Suite 400, Redmond, WA 98052 Phone: 425-899-2273 Fax: 425-899-2272 | |
Kumiko Y. Nomoto, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2701 156th Ave Ne, Redmond, WA 98052 Phone: 425-883-5020 | |
Franklin Dean Carr, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2701 156th Ave Ne, Redmond, WA 98052 Phone: 425-883-5020 | |
Dr. Sonya Y Lee, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4900 150th Ave Ne, Redmond, WA 98052 Phone: 425-256-7538 Fax: 668-139-4418 | |
Yuyu Jeff Lin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8980 161st Ave Ne, Suite 400, Redmond, WA 98052 Phone: 425-899-2273 Fax: 425-899-2272 | |
Dr. Roberto Carlos Barcelona Collantes, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 17209 Redmond Way, Redmond, WA 98052 Phone: 425-635-6400 | |
Pen Hou, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 17530 Ne Union Hill Rd, Ste 140, Redmond, WA 98052 Phone: 425-310-6519 Fax: 425-968-9839 |